Discover 1,934 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,934
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
for
Wound, Foot, Diabetic Foot Ulcer (DFU), Venus Leg Ulcer
Location: Coral Gables FL, Miami FL, Houston TX, Indianapolis IN,
Sponsor: Capsicure, LLC
Sex: All
Age: 18+
Code: NCT07701590
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
for
Cardiovascular, Metabolic Disease, Dyslipidemias,
Location: Hialeah FL, Orlando FL, Port Orange FL, Jacksonville FL,
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18 - 70+
Code: NCT07491172
Phase 1, Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Miami FL, Hialeah FL, Margate FL, Coconut Creek FL,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Miami FL, Houston TX, Canton OH, New Hyde Park NY,
Sponsor: Hoth Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05639933
Phase 2, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)